Monoclonal antibodies (mAbs) are currently the largest and most dominant class of therapeutic proteins. Inter-individual variability has been observed for several mAbs; however, an understanding of the underlying mechanisms and factors contributing to inter-subject differences in mAb disposition is still lacking. In this review, we analyze the mechanisms of antibody disposition and the putative mechanistic determinants of inter-individual variability. Results from in vitro, preclinical, and clinical studies were reviewed evaluate the role of the neonatal Fc receptor and Fc gamma receptors (expression and polymorphism), target properties (expression, shedding, turnover, internalization, heterogeneity, polymorphism), and the influence of anti-drug antibodies. Particular attention is given to the influence of co-administered drugs and disease, and to the physiological relevance of covariates identified by population pharmacokinetic modeling, as determinants of variability in mAb pharmacokinetics.
Keywords: co-administered drugs; disease; inter-subject variability; monoclonal antibodies; pharmacokinetics.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.Clin Pharmacokinet. 2016 Jul;55(7):789-805. doi: 10.1007/s40262-015-0361-4. Clin Pharmacokinet. 2016. PMID: 26818483 Review.
Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies.J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):427-46. doi: 10.1007/s10928-016-9482-0. Epub 2016 Jul 4. J Pharmacokinet Pharmacodyn. 2016. PMID: 27377311
Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.J Pharmacokinet Pharmacodyn. 2015 Oct;42(5):527-40. doi: 10.1007/s10928-015-9444-y. Epub 2015 Sep 12. J Pharmacokinet Pharmacodyn. 2015. PMID: 26364301
Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms.MAbs. 2017 Jul;9(5):781-791. doi: 10.1080/19420862.2017.1320008. Epub 2017 Apr 25. MAbs. 2017. PMID: 28440708 Free PMC article.
Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis.Clin Pharmacokinet. 2015 Nov;54(11):1107-23. doi: 10.1007/s40262-015-0296-9. Clin Pharmacokinet. 2015. PMID: 26123705 Review.